Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

You can’t have Emergency Use Authorization of a vaccine, if you...

First 6548 Last

Share
Profile

Follow
querci

73 Posts.

12

12/07/21

19:01

Post #: 54451054
Share

Originally posted by Empboss: ↑

quite the eye popper isn't it.

This may or may not be why its taking so long for the FDA to cooperate with IHL.

If I was Joel and the team, I'd be sitting comfortably with my trial results with a cigar in one hand, cognac in the other and feet up on my desk with a sparkle in my smile. Remember now, the in-vivo and in-vitro trial results both outperformed what our BOD had stated on paper.

Assuming we're all on the same page but we know CBD works and we certainly know HCQ works as it's already been cleared as a usable drug by the FDA and TGA for >decades< only to be restricted all of a sudden around mid last year in 2020.

FYI, HCQ was discovered as a covid suppressor/killer in late 2019 to early 2020 in a non clinical environment though... the results still showed favourably with patients who had c-19 like symptoms.

Since HCQ and CBD have individual clinical data to show it's efficacy and safety, and our combination drug IHL-675A is a new combination drug that the FDA/TGA have no past results to draw from, then with that being said, we're on our way for pretty much guaranteed EUA.

That's fantastic news.

AIMO though.
DYOR.

Expand

You can’t have Emergency Use Authorization of a vaccine, if you have an effective treatment.

IHL Price at posting: 26.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

MM1

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

AZY

Antipa's Minyari Dome reveals gold up to 24g/t through drilling at key prospect

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

There are more pages in this discussion • 13,368 more messages in this thread...

First 6548 Last

Add IHL (ASX) to my watchlist

SPONSORED BY